WELL — WELL Health Technologies Income Statement
0.000.00%
Last trade - 00:00- CA$960.70m
- CA$1.71bn
- CA$1.40bn
Annual income statement for WELL Health Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 302 | 569 | 776 | 920 | 1,400 |
| Cost of Revenue | |||||
| Gross Profit | 154 | 303 | 372 | 363 | 619 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 321 | 525 | 761 | 975 | 1,327 |
| Operating Profit | -18.4 | 44.3 | 15.3 | -55.1 | 72.8 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -25.5 | 17.5 | 19.5 | 8.99 | 5.31 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -31.3 | 18.7 | 16.6 | 29.1 | 4.46 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -44.2 | 1.37 | 0.082 | 32.6 | -7.36 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -44.2 | 1.37 | 0.082 | 32.6 | -7.36 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.18 | -0.048 | 0.096 | 0.188 | 0.041 |